SOURCE: Leerink Swann & Company

June 30, 2005 10:09 ET

Leerink Swann & Company Initiates Coverage of Express Scripts, Inc. (NASDAQ: ESRX)

BOSTON, MA -- (MARKET WIRE) -- June 30, 2005 -- This morning, Senior Health Care Services Analyst, Ann Hynes, initiated coverage of Express Scripts, Inc. (NASDAQ: ESRX) with an Outperform rating. Her investment rating is based on her belief that the company is well positioned to benefit from strong industry trends and continued leverage of its CuraScript platform provides an additional strong source for growth.

About Express Scripts, Inc.

Express Scripts, Inc. (NASDAQ: ESRX) is one of the largest pharmacy benefit management (PBM) companies in North America. Its integrated PBM services include network pharmacy claims processing, mail pharmacy services, benefit design consultation, drug utilization review, formulary management, disease management, and medical and drug data analysis services. Express Scripts also provides distribution services for specialty pharmaceuticals through its Specialty Distribution subsidiary. The company is headquartered in St. Louis, Missouri.

About Leerink Swann & Company

Leerink Swann & Company is an investment banking firm that provides healthcare equity research, corporate finance, and asset management services for institutional and high-net-worth clients. Leerink Swann & Company was voted the Best Firm in Biotechnology, Medical Supplies and Devices, Pharmaceuticals/Major and Pharmaceuticals/Specialty in the December 2004 Institutional Investor poll ranking the best boutique and regional firms by sector. Through its consulting affiliate, MEDACorp, Leerink Swann & Company provides biomedical-consulting services to Life Sciences companies and to the institutional investment community. MEDACorp includes thousands of biomedical professionals and practicing physicians. Leerink Swann & Company is a member NASD/SIPC.

Contact Information

  • Contact:
    John I. Fitzgerald
    Leerink Swann & Company
    (617) 918-4564